跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

gelatinase A inhibitors (wound healing)

首页药物gelatinase A inhibitors (wound healing)

gelatinase A inhibitors (wound healing)

未知生产厂商

生成 AI 研报

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
US 6307089 B2申请人: WARNER LAMBERT CO优先权: 2000
US
2 件公开
Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases
US 6624196 B2申请人: WARNER LAMBERT CO优先权: 2001
US
2 件公开
Fluorine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
US 6265432 B1申请人: WARNER LAMBERT CO优先权: 2000
US
Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
US 6399612 B1申请人: WARNER LAMBERT CO优先权: 2000
US
Enoxaparin and methods of its use
US 2002128226 A1申请人: KERN CHRISTOPHER优先权: 2000
US
Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases
US 6350885 B1申请人: WARNER LAMBERT CO优先权: 2001
US